Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tabuk Pharmaceuticals is a leading Saudi Arabian pharmaceutical company that develops, manufactures, and distributes a wide range of generic and value-added medicines. Established in 1994, it has grown to become one of the largest private pharmaceutical entities in the Middle East and North Africa (MENA) region. The company operates state-of-the-art manufacturing facilities in Saudi Arabia, Egypt, and Sudan, producing diverse dosage forms including solids, liquids, and sterile injectables. Tabuk's extensive portfolio covers critical therapeutic areas such as cardiovascular health, central nervous system disorders, and infectious diseases. Through strategic partnerships with global pharmaceutical giants like Pfizer and AbbVie, the company also provides contract manufacturing and localization services. Tabuk is a key subsidiary of the Astra Industrial Group and is committed to improving regional healthcare access through high-quality, affordable medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tabuk Pharmaceutical Manufacturing.